{"member_organisations": "", "identification_number": "878238423039-24", "fields_of_interest": "Economy, finance and the euro, Trade, International co-operation and development, Employment and Social Affairs, Environment, Maritime affairs and fisheries, Regional Policy, Research and innovation, Public Health, Food Safety, Transport, Communication, Banking and financial services", "head_office_address": "531 South Spring Street", "full_time_equivalent_fte": "1,5", "person_with_legal_responsibility": "Sandra Van der Vaart", "industry_forums": "", "grants": "", "country_code": "us", "inter_groups": "", "eu_initiatives": "\u2022    Directive 2001/20/EC relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. \n \n\u2022    Regulation 536/2014 on clinical trials on medicinal products for human use  \n \n\u2022    Directive 98/79/EC on in vitro diagnostic medical device \n \n\u2022    Commission Directive (EU) 2015/566, as regards the procedures for verifying the equivalent standards of quality and safety of imported tissues and cells \n \n\u2022    Directive 2010/63 on protection of animals used for scientific purposes \n \n\u2022    Regulation (EC) No 178/2002 laying down the general principles and requirements of food law \n \n\u2022    Directive 95/46/EC on the protection of individuals with regard to the processing of personal data and on the free movement of such data \n \nMobileHealth related initiatives", "level_of_interest": "global", "organisation_name": "Laboratory Corporation of America Holdings (LabCorp)", "belgium_office_post_code": "", "number_of_persons_involved": "4", "person_in_charge_of_eu_relations": "Sabine Schneider Nash", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "-79.4385891185106", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "17/08/2016", "estimate_of_costs_absolute_amount": "", "website_address": "http://labcorp.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Burlington", "membership": "- European Federation of the Pharmaceutical Industry and Associations (EFPIA), Partner in Research \n- Association of the British Pharmaceutical Industry (ABPI), Research Affiliate \n- European Animal Research Association (EARA) \n- Association of Clinical Research Associations (ACRO) \n- Antimicrobial Resistance Alliance", "head_office_post_code": "27215", "position": "VP Government Relations and Communications Europe/APAC", "financial_year_start_date": "01/01/2017", "head_office_country": "United States", "number_of_ep_accredited_persons": "", "relevant_communication": "LabCorp currently focuses on monitoring legislation, policies and directives and working through Associations such as EFPIA and ACRO to give guidance on areas impacted.", "financial_year_end_date": "01/12/2017", "lat": "36.0918149180604", "estimate_of_costs_as_a_range": "400000-499999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "LabCorp\u00ae is a leading global life sciences company that is deeply integrated in guiding patient care. Through its two business segments, LabCorp Diagnostics and Covance Drug Development, the company provides comprehensive clinical laboratory and end-to-end drug development services. By bringing together world-class diagnostics and drug development capabilities, LabCorp is positioned at the convergence of research and care delivery to enable more precise and individualized healthcare", "belgium_office_city": "", "head_office_phone": "(+1)3362291127"}